[
  {
    "ts": null,
    "headline": "2 Healthcare Stocks Poised for a Comeback in 2026",
    "summary": "Don't wait too long to press the buy button on these comeback stories.",
    "url": "https://finnhub.io/api/news?id=f638247f8883298392f657651534618ba833c83d79250b99c61af86fdb50dcf7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769106300,
      "headline": "2 Healthcare Stocks Poised for a Comeback in 2026",
      "id": 138206993,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Don't wait too long to press the buy button on these comeback stories.",
      "url": "https://finnhub.io/api/news?id=f638247f8883298392f657651534618ba833c83d79250b99c61af86fdb50dcf7"
    }
  },
  {
    "ts": null,
    "headline": "Antibody Discovery Market to Hit USD 35.35 Billion by 2035, Driven by AI and Technology Innovations",
    "summary": "The global antibody discovery market, valued at USD 11.15 billion in 2025, is expected to surge to USD 35.35 billion by 2035, growing at a CAGR of 12.23%. This growth is fueled by advancements in engineering technologies, automation, and AI, benefiting the development of fully human and humanized antibodies, which enhance therapeutic attributes. Major technologies like phage display and glycoengineering propel this trend. AI and machine learning are streamlining discovery, while innovations such",
    "url": "https://finnhub.io/api/news?id=435cada3a0acb1f47172afe892bcf8313e742325ea058384a0dc6d2cb446c78b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769097660,
      "headline": "Antibody Discovery Market to Hit USD 35.35 Billion by 2035, Driven by AI and Technology Innovations",
      "id": 138205964,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "The global antibody discovery market, valued at USD 11.15 billion in 2025, is expected to surge to USD 35.35 billion by 2035, growing at a CAGR of 12.23%. This growth is fueled by advancements in engineering technologies, automation, and AI, benefiting the development of fully human and humanized antibodies, which enhance therapeutic attributes. Major technologies like phage display and glycoengineering propel this trend. AI and machine learning are streamlining discovery, while innovations such",
      "url": "https://finnhub.io/api/news?id=435cada3a0acb1f47172afe892bcf8313e742325ea058384a0dc6d2cb446c78b"
    }
  }
]